KINRIX 25 [iU]/.5mL
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine · INJECTION, SUSPENSION · GlaxoSmithKline Biologicals SA
KINRIX is a injection, suspension containing diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine at 25 [iU]/.5mL, taken intramuscular. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- KINRIX
- Generic Name
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- NDC Code (Product)
58160-812- Manufacturer
- GlaxoSmithKline Biologicals SA
- Strength
- 25 [iU]/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125260
- Marketing Start
- 07/09/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is KINRIX used for?
KINRIX contains Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is KINRIX a controlled substance?
KINRIX is not classified as a controlled substance by the DEA.
What is the generic name for KINRIX?
The generic name for KINRIX is Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine. There are 1 other brand versions of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine.
What is the NDC code for KINRIX 25 [iU]/.5mL?
The NDC (National Drug Code) for KINRIX 25 [iU]/.5mL is 58160-812, listed by GlaxoSmithKline Biologicals SA.